Skip to content

Pfizer Expands ‘An Accord for a More healthy World’ Product Providing to Embody Full Portfolio for Better Profit to 1.2 Billion Individuals in 45 Decrease-Earnings Nations

  • Merchandise supplied on a not-for-profit foundation to the 45 lower-income international locations now embody the total portfolio for which Pfizer has international rights.

  • Expands on the preliminary providing of all patented medicines and vaccines accessible within the US or EU to now embody off-patent medicines, bringing complete providing from 23 to round 500 merchandise.

  • Builds on already delivered medicines and vaccines together with medical coaching and provide chain assist to Rwanda and superior conversations with 16 different Accord nation governments for provide and well being system assist.

DAVOS, Switzerland, January 17, 2023–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) right now introduced that it has considerably expanded its dedication to An Accord for a More healthy World to supply the total portfolio of medicines and vaccines for which it has international rights on a not -for-profit foundation to allow better well being for 1.2 billion individuals residing in 45 lower-income international locations.

Launched in Could 2022, the Accord, a transformative initiative centered on tremendously decreasing well being inequities that exist between many lower-income international locations and the remainder of the world, initially included a dedication from Pfizer for entry to all its patented medicines and vaccines accessible within the US or European Union on a not-for-profit foundation to 45 lower-income international locations. Nonetheless, to raised align with illness burden and unmet affected person wants in these international locations, Pfizer will now develop its providing beneath the Accord to incorporate off-patent merchandise, bringing the overall providing from 23 merchandise to round 500 merchandise.

The Accord portfolio providing now consists of each patented and off-patent medicines and vaccines that deal with or forestall most of the best infectious and non-communicable illness threats confronted right now in lower-income international locations. This consists of chemotherapy and oral most cancers therapies which have the potential to deal with almost a million new most cancers circumstances in Accord international locations every yearone. It additionally consists of a variety of antibiotics, which may also help to handle the rising morbidity, mortality and prices related to antimicrobial resistance (AMR) and assist to stop round 1.5 million deaths that happen every year in these international locations because of bacterial infections in hospitals and neighborhood well being clinics2. As Pfizer launches new medicines and vaccines, these merchandise can even be included within the Accord portfolio on a not-for-profit foundation.

“We launched the Accord to assist scale back the evident well being fairness hole that exists in our world. Our hope is to empower nation governments and co-create options with them and different multi-sector companions to interrupt down most of the system-level boundaries to raised well being.Within the months because the Accord’s launch, we’ve heard resoundingly from these leaders that entry to a broader and extra speedy scope of constant, high-quality merchandise is required for significant and sustainable transformation.We consider this enlargement of our product providing , mixed with continued efforts to assist handle the boundaries that restrict or forestall entry, will assist us to attain and even expedite our imaginative and prescient of a world the place all individuals have entry to the medicines and vaccines they should stay longer and more healthy lives,” stated Pfizer Chairman and CEO Albert Bourla.

Since its launch in Could 2022, An Accord for a More healthy World continues to make progress towards its targets to assist handle international well being fairness by means of each drugs and vaccine provide and well being system strengthening. Rwanda has already obtained supply of 9 Pfizer medicines and vaccines for the remedy of sure cancers, infectious and inflammatory illnesses. In collaboration with the Rwandan Ministry of Well being, Pfizer has supplied skilled healthcare schooling and coaching to assist the supply, and in November, Pfizer deployed its first World Well being Workforce to the nation to assist determine alternatives for long-term provide chain optimization. Collaboration can also be underway with the Ministries of Well being in Malawi, Ghana and Senegal in addition to plenty of different Accord international locations to raised perceive the essential healthcare wants and alternatives for well being system strengthening.

“The Accord is a crucial step in direction of sustainable well being safety for Rwanda and the broader continent. The expanded portfolio providing, mixed with public well being system strengthening efforts, will additional improve our progress and provide beneficial assist to key nationwide well being initiatives that result in optimistic well being outcomes,” stated His Excellency Paul Kagame, President of Rwanda.

About An Accord for a More healthy World

An Accord for a More healthy World is working to shut the well being fairness hole that persists between rich nations and plenty of lower-income international locations. The initiative is targeted on enabling better entry to healthcare for 1.2 billion individuals residing in 45 lower-income international locations, together with all 27 low-income international locations in addition to 18 lower-middle-income international locations which have transitioned from low to lower-middle-income classification within the final ten years. Alongside governments and multi-sector companions, Pfizer is working to co-create scalable options that assist handle systemic boundaries to raised well being centered on discovering quicker, extra environment friendly pathways for provide of medicines and vaccines in addition to strengthening the assets, capabilities and platforms that may allow fast and extra sustainable entry to these medicines. This consists of technical experience, coaching, diagnostic capability, progressive financing and extra. Beneath the Accord, Pfizer has dedicated to allow entry to the total portfolio of medicines and vaccines for which it owns international rights on a not-for-profit foundation to nationwide well being applications within the 45 Accord international locations. Additional particulars about An Accord for a More healthy World can be found at

About Pfizer: Breakthroughs That Change Sufferers’ Lives

At Pfizer, we apply science and our international assets to deliver therapies to individuals that reach and considerably enhance their lives. We attempt to set the usual for high quality, security and worth within the discovery, growth and manufacture of well being care merchandise, together with progressive medicines and vaccines. Day-after-day, Pfizer colleagues work throughout developed and rising markets to advance wellness, prevention, therapies and cures that problem probably the most feared illnesses of our time. In keeping with our accountability as one of many world’s premier progressive biopharmaceutical firms, we collaborate with well being care suppliers, governments and native communities to assist and develop entry to dependable, reasonably priced well being care around the globe. For greater than 170 years, we’ve labored to make a distinction for all who depend on us. We routinely put up info that could be vital to buyers on our web site at As well as, to study extra, please go to us on and comply with us on Twitter at @Pfizer and @PfizerNewsLinkedIn, YouTube and like us on Fb at

Disclosure Discover

The knowledge contained on this launch is as of January 17, 2023. The Firm assumes no obligation to replace forward-looking statements contained on this launch as the results of new info or future occasions or developments.

This launch accommodates forward-looking statements about ‘An Accord for A More healthy World,’ together with its potential advantages and the Firm’s efforts to develop its dedication beneath the Accord to supply the total portfolio of medicines and vaccines for which it has international rights on a not -for-profit foundation to 45 lower-income international locations and its collaborations with international well being leaders, that includes substantial dangers and uncertainties that would trigger precise outcomes to vary materially from these expressed or implied by such statements. Dangers and uncertainties embody, amongst different issues, the uncertainties inherent in analysis and growth, together with the flexibility to satisfy anticipated scientific endpoints, initiation and/or completion dates for our scientific trials, regulatory submission dates, regulatory approval dates and/or launch dates, in addition to the potential for unfavorable new scientific knowledge and additional analyzes of current scientific knowledge; selections by regulatory authorities impacting labeling, manufacturing processes, security and/or different issues that would have an effect on the provision or business potential of Pfizer’s product candidates, together with growth of merchandise or therapies by different firms; manufacturing capabilities or capability; uncertainties relating to the flexibility to acquire suggestions from vaccine technical committees and different public well being authorities and uncertainties relating to the business influence of any such suggestions; the uncertainties inherent in enterprise and monetary planning, together with, with out limitation, dangers associated to Pfizer’s enterprise and prospects, opposed developments in Pfizer’s markets, or opposed developments within the US or international capital markets, credit score markets, regulatory surroundings or economies typically; uncertainties relating to the success of the Accord; the influence of COVID-19 on the Firm’s enterprise, operations and monetary outcomes; and aggressive developments.

An extra description of dangers and uncertainties will be present in Pfizer’s Annual Report on Kind 10-Ok for the fiscal yr ended December 31, 2021 and in its subsequent reviews on Kind 10-Q, together with within the sections thereof captioned “Threat Elements” and “Ahead-Trying Data and Elements That Could Have an effect on Future Outcomes”, in addition to in its subsequent reviews on Kind 8-Ok, all of that are filed with the US Securities and Trade Fee and accessible at and

one Inner calculations based mostly on now/fact-sheets-populations
2 Inner calculations based mostly on World mortality related to 33 bacterial pathogens in 2019: a scientific evaluation for the World Burden of Illness Research 2019 (

View supply model on


media relations
+1 (212) 733-1226

Investor Relations
+1 (212) 733-4848

Leave a Reply

Your email address will not be published. Required fields are marked *